Amedica Receives FDA Approval for Interbody Fusion Device

Amedica, a spinal and reconstructive medical device manufacturer, has received 510(k) clearance from the FDA to legally market a second generation family of cervical and lumbar interbody fusion devices manufactured with the company’s proprietary silicon nitride biomaterial.

Advertisement

The product portfolio expansion offers design enhancements including a threaded insertion feature, additional footprints and design elements that will allow surgeons to perform minimally invasive and lumbar lateral interbody fusion approaches.

More Articles on Orthopedic Devices:

Smith Nephew Updates Indications for Birmingham Hip Implants

Biomet Announces Lifetime Warranty on Oxford Partial Knee

EOS imaging Announces First Installation in Asia

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.